Leah R. Hanson, Ph.D.

Dr. Hanson is an internationally recognized expert in the development and use of intranasally-administered therapeutics to target the brain for treatment of disease associated with neurodegenerative disorders. As a Senior Research Investigator and Senior Director of Neuroscience Research at HealthPartners Institute and Co-Director of Research at the HealthPartners Center for Memory and Aging, she directly manages the HealthPartners Institute laboratory facilities and staff trained in conducting small and large animal studies. Dr. Hanson’s career has been devoted to the development of novel therapeutic delivery methods for the treatment and prevention of neurologic diseases, especially those that impact older adults such as Alzheimer’s, Parkinson’s disease, and stroke. She has numerous publications and patents in the field of intranasal delivery with a wide range of experience from leading numerous pre-clinical to clinical studies to experience with infrastructure projects and observational studies.